Inhibins/activins as diagnostic markers for ovarian cancer

Molecular and Cellular Endocrinology

Volumn 191, Issue 1, 2002, Pages 97-103

  Robertson, D M ^a   Stephenson, T ^a   Pruysers, E ^a   Burger, H G ^a   McCloud, P ^b   Tsigos, A ^c   Groome, N ^c   Mamers, P ^d   McNeilage, J ^d   Jobling, T ^d   Healy, D ^d  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b Roche Products Pty Ltd   (Australia)

^c OXFORD BROOKES UNIVERSITY   (United Kingdom)

^d MONASH UNIVERSITY   (Australia)

Author keywords

ELISA; Granulosa cell tumour; Inhibin subunit; Mucinous carcinoma

Indexed keywords

ACTIVIN; BIOCHEMICAL MARKER; CA 125 ANTIGEN; INHIBIN; INHIBIN A; INHIBIN B; FOLLITROPIN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; TUMOR MARKER;

BLOOD ANALYSIS; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TUMOR DIAGNOSIS; BLOOD; GRANULOSA CELL TUMOR; METABOLISM; OVARY TUMOR; REVIEW;

ACTIVINS; ANTIBODIES, MONOCLONAL; FEMALE; FOLLICLE STIMULATING HORMONE; GRANULOSA CELL TUMOR; HUMAN; INHIBINS; OVARIAN NEOPLASMS; PROTEIN SUBUNITS; SUPPORT, NON-U.S. GOV'T; TUMOR MARKERS, BIOLOGICAL; HUMANS;

EID: 0037204683     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(02)00060-6     Document Type: Conference Paper

References (46)

1. Is potential to produce inhibins related to prognosis in ovarian granulosa cell tumors?
2. The performance of screening tests for ovarian cancer: results of a systematic review
3. The post-operative gonadotropin level in post-menopausal women with epithelial ovarian cancer
4. Characterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours
5. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women
6. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors
7. Follistatin is a modulator of gonadal tumor progression and the activin- induced wasting syndrome in inhibin-deficient mice
8. Inhibin as a marker for ovarian cancer
9. Inhibin immunoreactivity in gonadal and non-gonadal tumors
10. Testicular Sertoli cell tumor with a heterologous sarcomatous component: immunohistochemical assessment of Sertoli cell differentiation
11. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
12. Quantitation of inhibin Pro-αC-containing forms in human serum by a new ultrasensitive two-site enzyme-linked immunosorbent assay
13. Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue
14. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumours
15. Ovarian cancer: epidemiology, biology, and prognostic factors
16. Expression of inhibin alpha, beta A and beta B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome
17. A prospective study of inhibin in granulosa cell tumors of the ovary
18. Roles of inhibins, activins, and follistatin in the female reproductive system
19. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study
20. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis
21. Multiple immunoreactive inhibin proteins in serum from postmenopausal women with epithelial ovarian cancer
22. Secretion of activin A in recurrent epithelial ovarian carcinoma
23. Inhibin as a marker for granulosa cell tumours
24. Activins, inhibins, and follistatins: further thoughts on a growing family of regulators
25. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice
26. Role of tumour markers in monitoring epithelial ovarian cancer
27. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy
28. Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors
29. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma
30. A comparative study of serum alpha-beta A immunoreactive inhibin and tumor-associated antigens CA125 and CEA in ovarian cancer
31. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors
32. Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle
33. The biological and immunological characterisation of inhibin A and B forms in human follicular fluid and plasma
34. Inhibin forms in serum from postmenopausal women with ovarian cancers
35. Combined inhibin and CA125 assays in the detection of ovarian cancer
36. Development of an inhibin α subunit ELISA with broad specificity
37. Peripheral vein, ovarian vein and ovarian tissue levels of inhibin in a postmenopausal patient with a granulosa cell tumour
38. Markers supplementing CA 125 in ovarian cancer
39. Inhibin gene expression in a large cell calcifying Sertoli cell tumour and serum inhibin and activin levels
40. The inhibin/activin family of hormones and growth factors
41. Ovarian cancer identified through screening with serum markers but not by pelvic imaging
42. Immunohistochemical localization of inhibin and activin subunits in human epithelial ovarian tumors
43. Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle